Giuseppe Basso

Active 1980–2024

156
Papers
31,832
Citations
99
h-index
155
i10-index

Citations

Citations per year for Giuseppe Basso1982: 1 citations1988: 2 citations1989: 1 citations1991: 1 citations1992: 2 citations1993: 1 citations1994: 2 citations1995: 6 citations1996: 10 citations1997: 19 citations1998: 33 citations1999: 42 citations2000: 80 citations2001: 50 citations2002: 87 citations2003: 79 citations2004: 69 citations2005: 68 citations2006: 80 citations2007: 104 citations2008: 196 citations2009: 274 citations2010: 285 citations2011: 272 citations2012: 492 citations2013: 476 citations2014: 430 citations2015: 548 citations2016: 447 citations2017: 400 citations2018: 372 citations2019: 1,184 citations2020: 1,187 citations2021: 1,113 citations2022: 750 citations2023: 528 citations2024: 801 citations2025: 296 citations2026: 4 citations1983–1987: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,492 citing papers, 25.8% of this breakdownChina: 1,371 citing papers, 10.1% of this breakdownItaly: 1,010 citing papers, 7.5% of this breakdownGermany: 976 citing papers, 7.2% of this breakdownUnited Kingdom: 721 citing papers, 5.3% of this breakdownFrance: 548 citing papers, 4% of this breakdownNetherlands: 465 citing papers, 3.4% of this breakdownSpain: 382 citing papers, 2.8% of this breakdownCanada: 372 citing papers, 2.8% of this breakdownJapan: 363 citing papers, 2.7% of this breakdownAustralia: 289 citing papers, 2.1% of this breakdownSwitzerland: 269 citing papers, 2% of this breakdown
0%25.8%Other 24.3%

Fields

  • Medicine45.8%
  • Biochemistry, Genetics and Molecular Biology38.4%
  • Immunology and Microbiology11.7%
  • Agricultural and Biological Sciences0.9%
  • Neuroscience0.8%
  • Engineering0.6%
  • Other1.8%

Topics

  • Acute Lymphoblastic Leukemia research8.1%
  • Acute Myeloid Leukemia Research5.9%
  • Hippo pathway signaling and YAP/TAZ3.8%
  • Immune cells in cancer3.4%
  • Childhood Cancer Survivors' Quality of Life2.8%
  • Epigenetics and DNA Methylation2.7%
  • Other73.3%

Coauthors

All papers

Open in search
  1. YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response

    Authors: , , , , , , , , , , , , - Cell 2014 cited by 1,105

  2. The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

    Authors: , , , , , , , , , , , , , , - Cell 2011 cited by 1,398

  3. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng Cheng, Stefan Roberts, Michael I. Barbato, Dario Campana, Elaine Coustan‐Smith, Sheila Shurtleff, Susana C. Raimondi, Maria Kleppe, Jan Cools, Kristin A. Shimano, Michelle L. Hermiston, Sergei Doulatov, Kolja Eppert, Elisa Laurenti, Faiyaz Notta, John E. Dick, Giuseppe Basso, Stephen P. Hunger, Mignon L. Loh, Meenakshi Devidas, Brent L. Wood, Stuart S. Winter, Kimberly P. Dunsmore, Robert S. Fulton, Lucinda Fulton, Xin Hong, Christopher Harris, David J. Dooling, Kerri Ochoa, Kimberly Johnson, John C. Obenauer, William E. Evans, Ching‐Hon Pui, Clayton W. Naeve, Timothy J. Ley, Elaine R. Mardis, Richard K. Wilson, James R. Downing, Charles G. Mullighan - Nature 2012 cited by 1,639

  4. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , - The Lancet Oncology 2009 cited by 1,016

  5. Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor

    Authors: , , , , , , , , , , , , , , , - Immunity 2010 cited by 845

  6. The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brent L. Wood, Nyla A. Heerema, Andrew Carrol, Yung‐Li Yang, Malcolm A. Smith, Tanja M. Davidsen, Leandro C. Hermida, Patee Gesuwan, Marco A. Marra, Yussanne Ma, Andrew J. Mungall, Richard A. Moore, Steven J.M. Jones, Marcus B. Valentine, Laura J. Janke, Jeffrey E. Rubnitz, Ching‐Hon Pui, Liang Ding, Yu Liu, Jinghui Zhang, Kim E. Nichols, James R. Downing, Xueyuan Cao, Lei Shi, Stanley Pounds, Scott Newman, Deqing Pei, Jaime M. Guidry Auvil, Daniela S. Gerhard, Stephen P. Hunger, Hiroto Inaba, Charles G. Mullighan - Nature 2018 cited by 374

  7. IKZF1plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Doris Steinemann, Oskar A. Haas, Renate Panzer‐Grümayer, Hélène Cavé, Richard S. Houlston, Gunnar Cario, Martin Schrappe, Martin Zimmermann, the International BFM Study Group - Journal of Clinical Oncology 2018 cited by 299

  8. Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Zachar, Madeleine Joubert, Janick Sèlves, Dominique Pasquier, Paulette Bioulac‐Sage, Michael A. Grotzer, Margaret Childs, Monique Fabrè, Marie‐Annick Buendia - Cancer Cell 2008 cited by 509

  9. Role of TAZ as Mediator of Wnt Signaling

    Authors: , , , , , , , - Cell 2012 cited by 497

  10. Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 675

  11. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cezmi A. Akdiş, Luca Mazzarella, Saverio Minucci, Pier Giuseppe Pelicci, Emanuela Marcenaro, Andrew N. J. McKenzie, Dominique Vanhecke, George Coukos, Domenico Mavilio, Antonio Curti, Laurent Derré, Camilla Jandus - Nature Communications 2017 cited by 226

  12. Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ

    Authors: , , , , , , , , , , , - Cell stem cell 2016 cited by 272

  13. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation

    Authors: , , , , , , , , , , , , , , - Genome biology 2020 cited by 127

  14. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2010 cited by 786

  15. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 cited by 71

  16. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2007 cited by 872

  17. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2008 cited by 227

  18. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olaf Heidenreich, Georg Hemmrich‐Stanisak, Kebria Hezaveh, Jessica I. Höll, Sabine Hornhardt, Peter Husemann, Priyadarshini Kachroo, Christian P. Kratz, Geertruy te Kronnie, Blerim Marovca, Felix Niggli, Alice C. McHardy, Anthony V. Moorman, Renate Panzer‐Grümayer, Britt Petersen, Benjamin Raeder, Meryem Ralser, Philip Rosenstiel, Daniel W. Schafer, Martin Schrappe, Stefan Schreiber, Moritz Schütte, Björn Stade, Ralf Thiele, Nicolas von der Weid, Ajay Vora, Markéta Žaliová, Langhui Zhang, Thomas Zichner, Martin Zimmermann, Hans Lehrach, Arndt Borkhardt, Jean‐Pierre Bourquin, André Franke, Jan O. Korbel, Martin Stanulla, Marie‐Laure Yaspo - Nature Genetics 2015 cited by 253

  19. Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruno Palhais, Pieter Van Vlierberghe, Tom Taghon, Iannis Aifantis, Young Ah Goo, Ernesto Guccione, Adriana Heguy, Aristotelis Tsirigos, Keng Boon Wee, Rama K. Mishra, Françoise Pflumio, Benedetta Accordi, Giuseppe Basso, Panagiotis Ntziachristos - Cancer Discovery 2020 cited by 101

  20. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 285

  21. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles G. Mullighan, Atsushi Manabe, Gabriele Escherich, Jerzy Kowalczyk, James A. Whitlock, C. Michel Zwaan - Blood 2013 cited by 247

  22. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 171

  23. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2006 cited by 785

  24. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 351